Acute Technical Outcomes of the Talent Abdominal Aortic Aneurysm (AAA) Stent-Graft Versus Cook Zenith Stent-Graft
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | June 2009 |
| End Date: | June 2011 |
| Contact: | Deborah Hill, RN |
| Email: | hilld@albanyvascular.com |
| Phone: | 518 45202198 |
Acute Technical Outcomes of the Talent AAA Stent -Graft vs. Cook Zenith Stent- Graft: A Case-Control Study
The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent
Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical
Center and St. Peter's Hospital in Albany, NY.
The investigators are comparing the two devices as part of the evolution of endovascular
repair (EVAR) for AAAs. The Zenith AAA Endovascular Graft received FDA approval on May 23,
2003, the Talent Abdominal Stent Graft System on April 15, 2008.
Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical
Center and St. Peter's Hospital in Albany, NY.
The investigators are comparing the two devices as part of the evolution of endovascular
repair (EVAR) for AAAs. The Zenith AAA Endovascular Graft received FDA approval on May 23,
2003, the Talent Abdominal Stent Graft System on April 15, 2008.
Inclusion Criteria:
- subject with abdominal aortic aneurysm, with or without iliac involvement
- iliac/femoral access vessel morphology that is compatible with vascular access
techniques, devices, and/or accessories
Exclusion Criteria:
- less than 18 years of age
- pregnant or lactating
- have contraindications for use of contrast medium or anticoagulation drugs
- are patients who have a condition that threatens to infect the graft
- are patients with sensitivities or allergies to the device materials
We found this trial at
1
site
Click here to add this to my saved trials
